Shigella dysenteriae Antibodies

Santa Cruz Biotechnology offers a broad range of Shigella dysenteriae monoclonal antibodies for research focused on understanding this pathogenic bacterium. Shigella dysenteriae Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Shigella dysenteriae is a significant cause of bacillary dysentery, leading to severe gastrointestinal disease and posing a major public health threat, particularly in developing countries. Virulence factors from Shigella dysenteriae play crucial roles in bacterial invasion of epithelial cells and evasion of host immune responses. Research into Shigella dysenteriae molecular mechanisms continues to reveal new insights about pathogenesis and potential therapeutic targets. Advanced detection methods using specific molecular markers help track infection patterns and transmission routes in epidemiological studies. Understanding the complex interactions between Shigella dysenteriae and host cells is vital for developing effective therapeutic strategies and vaccines against shigellosis. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of this significant pathogen and contribute to improved public health outcomes.